Literature DB >> 330773

Antigens of Escherichia coli, human immune response, and the pathogenesis of urinary tract infections.

L A Hanson, S Ahlstedt, A Fasth, U Jodal, B Kaijser, P Larsson, U Lindberg, S Olling, A Sohl-Akerlund, C Svanborg-Edén.   

Abstract

Acute pyelonephritis (but not cystitis or "asymptomatic" bacteriuria) due to Escherichia coli induces serum antibodies to O-but rarely to K-antigens, especially not to the most common antigen, K1. Locally produced secretory IgA and IgG antibodies to O-and K-antigens appear in urine during most infections. The E. coli in urine of patients with asymptomatic bacteriuria are different from those in patients with acute pyelonephritis and cystitis and undergo continuous changes, presumably caused by the local antibody response. The E. coli become less virulent and are less able to attach to uroepithelial cells than E. coli causing acute symptomatic infections. Antibodies in urine prevent epithelial adherence. Parenteral and intravesicular injections of killed bacteria can protect against ascending pyelonephritis in rats. A few K-antigens dominate among E. coli that cause urinary tract infections. Vaccination of problem cases is a possibility because of the protective nature of K-antibodies. The mechanism of renal scarring that appears in some patients with urinary tract infections is unknown. Autoantibodies to the Tamm-Horsfall protein that increase after acute pyelonephritis or the cross-reactions noted between certain E. coli and antigens on the kidney may be involved.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330773     DOI: 10.1093/infdis/136.supplement.s144

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Efficacy of an enzyme-linked immunosorbent assay for detection of urinary tract immunoglobulins for diagnosis of urinary tract infections.

Authors:  J A Kellogg; J P Manzella; J W Seiple; S J Fortna; J W Cook; J S Levisky
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

2.  Adverse drug reactions during treatment of urinary tract infections.

Authors:  L E Böttiger; B Westerholm
Journal:  Eur J Clin Pharmacol       Date:  1977-07-19       Impact factor: 2.953

3.  Adhesion of Escherichia coli to human uroepithelial cells in vitro.

Authors:  C S Eden; B Eriksson; L A Hanson
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

4.  [Immunopathology of pyelonephritis].

Authors:  K Rother
Journal:  Klin Wochenschr       Date:  1983-10-17

5.  Opsonization of various capsular (K) E. coli by the alternative complement pathway.

Authors:  P Stevens; L S Young; S Adamu
Journal:  Immunology       Date:  1983-11       Impact factor: 7.397

6.  Structure of the Escherichia coli K2 capsular antigen, a teichoic acid-like polymer.

Authors:  K Jann; B Jann; M A Schmidt; W F Vann
Journal:  J Bacteriol       Date:  1980-09       Impact factor: 3.490

7.  Diagnostic value and biological significance of antibody-coated bacteria in urine.

Authors:  C Mengoli; E Arosio; D Bonato; G Spiazzi; P Pancera; G Montesi; A Lechi; L A Scuro
Journal:  J Clin Pathol       Date:  1980-02       Impact factor: 3.411

8.  Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.

Authors:  A Fomsgaard; R S Conrad; C Galanos; G H Shand; N Høiby
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

9.  Escherichia coli pili as possible mediators of attachment to human urinary tract epithelial cells.

Authors:  C S Edén; H A Hansson
Journal:  Infect Immun       Date:  1978-07       Impact factor: 3.441

10.  Efficacy of a Proteus mirabilis outer membrane protein vaccine in preventing experimental Proteus pyelonephritis in a BALB/c mouse model.

Authors:  N Moayeri; C M Collins; P O'Hanley
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.